Examining the Use of Biomarkers in Establishing the Presence and Severity of Impairments: Proceedings of a Workshop (2020)
Chapter: Appendix B: Workshop Agenda
Visit
NAP.edu/10766
to get more information about this book, to buy it in print, or to
download it as a free PDF.
Previous Chapter:
Appendix A: Statement of Task
Appendix B
Next Chapter: Appendix C: Biographical Sketches of Workshop Speakers and Planning Committee Members
Suggested Citation:
"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2020. Examining the Use of Biomarkers in Establishing the Presence and Severity of Impairments: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25926.
Appendix B
Workshop Agenda
JULY 21, 2020
| 10:00 a.m. | Welcome and Opening Remarks SARA ROSENBAUM, THE GEORGE WASHINGTON UNIVERSITY PLANNING COMMITTEE CHAIR |
| Sponsor Remarks from the Social Security Administration MARK WARSHAWSKY, SOCIAL SECURITY ADMINISTRATION |
|
| 10:15 a.m. | Session 1: Overview of Biomarkers Moderator: SARA ROSENBAUM, THE GEORGE WASHINGTON UNIVERSITY |
| Overview of Terminology and Biomarker Use in Clinical Decision Making JOSEPH MENETSKI, FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH |
|
| Where Do Biomarkers Fit When Trying to Relate Health to Function? AMY WAGNER, UNIVERSITY OF PITTSBURGH |
Suggested Citation:
"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2020. Examining the Use of Biomarkers in Establishing the Presence and Severity of Impairments: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25926.
| Panel Discussion | |
| 11:15 a.m. | Break |
| 11:30 a.m. | Session 2: Bioethical and Legal Considerations with the Use of Biomarkers to Establish Presence and Severity of Impairments Moderator: SARAH RUIZ, NATIONAL INSTITUTE ON DISABILITY, INDEPENDENT LIVING, AND REHABILITATION RESEARCH |
|
Panelists JEROME BICKENBACH, UNIVERSITY OF LUCERNE JUDITH COOK, UNIVERSITY OF ILLINOIS AT CHICAGO CENTER ON MENTAL HEALTH SERVICES RESEARCH AND POLICY KRISTI KIRSCHNER, UNIVERSITY OF ILLINOIS COLLEGE OF MEDICINE ANDREW PETERSON, GEORGE MASON UNIVERSITY |
|
| Panel Discussion | |
| 12:15 p.m. | Lunch Break |
| 12:45 p.m. | Session 3: State of the Science on Biomarkers to Establish Presence and Severity of Impairments: Part I (major depression, post-traumatic stress disorder, and schizophrenia) Moderator: LINDA BRADY, NATIONAL INSTITUTES OF HEALTH |
|
Panelists
MADHUKAR TRIVEDI, UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS AMIT ETKIN, STANFORD UNIVERSITY AND ALTO NEUROSCIENCE JEFFREY LIEBERMAN, COLUM BIA UNIVERSITY PHILIP HARVEY, UNIVERSITY OF MIAMI |
|
| Panel Discussion | |
| 2:20 p.m. | Break |
Suggested Citation:
"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2020. Examining the Use of Biomarkers in Establishing the Presence and Severity of Impairments: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25926.
| 2:35 p.m. | Session 3: State of the Science on Biomarkers to Establish Presence and Severity of Impairments: Part II (arthritis, chronic pain, and fibromyalgia) Moderator: ROBERT WALLACE, UNIVERSITY OF IOWA |
|
Panelists DANIEL CLAUW, UNIVERSITY OF MICHIGAN JOAN BATHON, COLUM BIA UNIVERSITY VIRGINIA BYERS KRAUS, DUKE MOLECULAR PHYSIOLOGY INSTITUTE GWENDOLYN SOWA, UNIVERSITY OF PITTSBURGH |
|
| Panel Discussion | |
| 4:15 p.m. | Session 5: Reactor Panel Moderator: SARA ROSENBAUM, THE GEORGE WASHINGTON UNIVERSITY |
|
Panelists
BETTY DIAMOND, HOFSTRA NORTHWELL SCHOOL OF MEDICINE SARAH MORRIS, NATIONAL INSTITUTES OF HEALTH RALPH NITKIN, NATIONAL INSTITUTES OF HEALTH IRA SHOULSON, UNIVERSITY OF ROCHESTER |
|
| 4:45 p.m. | Public Comment |
| 4:55 p.m. | Workshop Wrap-Up SARA ROSENBAUM, THE GEORGE WASHINGTON UNIVERSITY PLANNING COMMITTEE CHAIR |
| 5:00 p.m. | Adjourn |
Suggested Citation:
"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2020. Examining the Use of Biomarkers in Establishing the Presence and Severity of Impairments: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25926.
This page intentionally left blank.
Suggested Citation:
"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2020. Examining the Use of Biomarkers in Establishing the Presence and Severity of Impairments: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25926.
Suggested Citation:
"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2020. Examining the Use of Biomarkers in Establishing the Presence and Severity of Impairments: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25926.
Suggested Citation:
"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2020. Examining the Use of Biomarkers in Establishing the Presence and Severity of Impairments: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25926.
Suggested Citation:
"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2020. Examining the Use of Biomarkers in Establishing the Presence and Severity of Impairments: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25926.
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.